Ipratropium Bromide Solution
Product Images NDC 60687-394

6 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 60687-394). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.5 mg Per 2.5 mg Ipratropium Bromide Inhalation Soln Carton (Ipratropium Br Carton)

0.5 mg Per 2.5 mg Ipratropium Bromide Inhalation Soln Carton (Ipratropium Br Carton)
Ipratropium Bromide Inhalation Solution 0.5 mg/2.5 mL, 0.02% strength, in sterile unit-dose vials. The label indicates 30 x 2.5 mL vials per foil pouch for respiratory (inhalation) use. The product is labeled for oral inhalation and is manufactured by American Health Packaging. The packaging features dosing and storage information, including Rx only status.*
FDA Label Image

Ipratropium Bromide Inhalation Solution Foil Label (Rpfp0221 Ahp Ipratropium Bromide 0 5mg 30ct Foil Image 01)

Ipratropium Bromide Inhalation Solution Foil Label (Rpfp0221 Ahp Ipratropium Bromide 0 5mg 30ct Foil Image 01)
Ipratropium Bromide Inhalation Solution 0.02% (0.5 mg per vial) by American Health Packaging. The label specifies a 2.5 mL unit-dose vial with each vial containing 0.5 mg ipratropium bromide in isotonic sterile aqueous solution. It is intended for oral inhalation only, with storage instructions between 15° and 30°C. The label includes dosing guidance, pharmacist instructions, and the product NDC 60687-394.*
FDA Label Image

Chemical Structure (Ipratropium 01)

Chemical Structure (Ipratropium 01)
Chemical structure diagram of Ipratropium Bromide, showing its molecular arrangement including bromide and water (Br•H2O) components.*
FDA Label Image

Figure 1 (Ipratropium 02)

Figure 1 (Ipratropium 02)
An instructional illustration labeled "Figure 1" showing a person holding a small vial with a pull-apart top. The image depicts how to prepare the vial for use, with fingers grasping the vial and top, indicating the action to open it.*
FDA Label Image

Figure 2 (Ipratropium 03)

Figure 2 (Ipratropium 03)
An instructional illustration labeled Figure 2 showing a close-up of a hand operating a respiratory inhalation device, with arrows indicating a motion, likely demonstrating how to assemble or use the inhaler system.*
FDA Label Image

Figure 3 (Ipratropium 04)

Figure 3 (Ipratropium 04)
Illustration showing a person inhaling medication from an inhaler device, demonstrating correct usage by placing the mouthpiece in the mouth.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.